Novel [1,2,4]triazolo[3,4- b][1,3,4]thiadiazine and [1,2,4]triazolo[3,4- b][1,3,4]thiadiazepine Derivatives: Synthesis, Anti-Viral In Vitro Study and Target Validation Activity

Molecules. 2022 Nov 16;27(22):7940. doi: 10.3390/molecules27227940.

Abstract

This study of the interaction system of binucleophilic 3-substituted 4-amino-4H-1,2,4-triazole-5-thiols and 3-phenyl-2-propynal made it possible to develop a new approach to synthesis of such isomeric classes as 7-benzylidene-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine and 8-phenyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazepine. Among the 20 compounds studied in vitro against influenza A/Puerto Rico/8/34 (H1N1) virus, half of them demonstrated selectivity index (SI) of 10 or higher and one of them (4-((3-phenylprop-2-yn-1-yl)amino)-4H-1,2,4-triazole-3-thiol) possessed the highest (SI > 300). Docking results and values showed that the preferred interactant for our ligands was M2 proton channel of the influenza A virus. Protein-ligand interactions modeling showed that the aliphatic moiety of ligands could negatively regulate target activity level.

Keywords: [1,2,4]triazolo[3,4-b][1,3,4]thiadiazepines; [1,2,4]triazolo[3,4-b][1,3,4]thiadiazines; annelated heterocycles; anti-viral activity; drug design; influenza virus.

MeSH terms

  • Antiviral Agents / pharmacology
  • Influenza A Virus, H1N1 Subtype*
  • Ligands
  • Thiadiazines* / pharmacology
  • Triazoles / pharmacology

Substances

  • Thiadiazines
  • Antiviral Agents
  • Triazoles
  • Ligands

Grants and funding

This research was funded by the Russian Foundation for Basic Research and the Committee on Science of the Republic of Armenia within the framework of the scientific project No. 20-53-05010 Arm_a/20RF-138; by the grant program for young scientists FASIE (2022–2023) No. 17837GU/2022.